CHA Biotech Co. Ltd (085660) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.063x

Based on the latest financial reports, CHA Biotech Co. Ltd (085660) has a cash flow conversion efficiency ratio of -0.063x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-64.01 Billion ≈ $-43.38 Million USD) by net assets (₩1.02 Trillion ≈ $689.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 085660 net asset quality index to measure how much of total assets are equity-financed.

CHA Biotech Co. Ltd - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how CHA Biotech Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 085660 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

CHA Biotech Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CHA Biotech Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Bansal Wire Industries Ltd NSE:BANSALWIRE	0.104x
Gresgying Digital Energy Technology Co Ltd SHG:600212	0.058x
Amos Luzon Development and Energy Group Ltd TA:LUZN	-0.056x
Societe de la Tour Eiffel SA PA:EIFF	0.036x
Nanjing Develop Advanced Manufacturing Co Ltd SHG:688377	0.048x
Sarkuysan Elektrolitik Bakir Sanayi ve Ticaret AS IS:SARKY	-0.017x
Invesco Mortgage Capital Inc NYSE:IVR	0.047x
Datamatics Global Services Limited NSE:DATAMATICS	0.082x

Annual Cash Flow Conversion Efficiency for CHA Biotech Co. Ltd (2009–2025)

The table below shows the annual cash flow conversion efficiency of CHA Biotech Co. Ltd from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see 085660 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩809.25 Billion ≈ $548.42 Million	₩-72.52 Billion ≈ $-49.15 Million	-0.090x	+48.51%
2024-12-31	₩284.69 Billion ≈ $192.93 Million	₩-49.55 Billion ≈ $-33.58 Million	-0.174x	-1092.29%
2023-12-31	₩656.33 Billion ≈ $444.79 Million	₩11.51 Billion ≈ $7.80 Million	0.018x	+124.80%
2022-12-31	₩291.73 Billion ≈ $197.70 Million	₩-20.63 Billion ≈ $-13.98 Million	-0.071x	-245.08%
2021-12-31	₩456.06 Billion ≈ $309.06 Million	₩22.23 Billion ≈ $15.06 Million	0.049x	-63.17%
2020-12-31	₩355.09 Billion ≈ $240.64 Million	₩47.00 Billion ≈ $31.85 Million	0.132x	+97.78%
2019-12-31	₩377.18 Billion ≈ $255.61 Million	₩25.24 Billion ≈ $17.10 Million	0.067x	-70.97%
2018-12-31	₩326.99 Billion ≈ $221.60 Million	₩75.38 Billion ≈ $51.09 Million	0.231x	+342.94%
2017-12-31	₩230.74 Billion ≈ $156.37 Million	₩12.01 Billion ≈ $8.14 Million	0.052x	+31.95%
2016-12-31	₩286.32 Billion ≈ $194.04 Million	₩11.29 Billion ≈ $7.65 Million	0.039x	-81.50%
2015-12-31	₩290.10 Billion ≈ $196.60 Million	₩61.86 Billion ≈ $41.92 Million	0.213x	+3732.73%
2014-12-31	₩437.45 Billion ≈ $296.46 Million	₩-2.57 Billion ≈ $-1.74 Million	-0.006x	-104.53%
2013-12-31	₩512.34 Billion ≈ $347.21 Million	₩66.35 Billion ≈ $44.97 Million	0.130x	-6.23%
2012-12-31	₩331.41 Billion ≈ $224.59 Million	₩45.77 Billion ≈ $31.02 Million	0.138x	+13.63%
2011-12-31	₩285.46 Billion ≈ $193.45 Million	₩34.69 Billion ≈ $23.51 Million	0.122x	-54.29%
2010-12-31	₩158.24 Billion ≈ $107.24 Million	₩42.07 Billion ≈ $28.51 Million	0.266x	+39.05%
2009-12-31	₩125.61 Billion ≈ $85.12 Million	₩24.02 Billion ≈ $16.28 Million	0.191x	--

About CHA Biotech Co. Ltd

KQ:085660 Korea Biotechnology

Market Cap

$532.39 Million

₩785.59 Billion KRW

Market Cap Rank

#11707 Global

#301 in Korea

Share Price

₩8450.00

Change (1 day)

+5.23%

52-Week Range

₩8030.00 - ₩23850.00

All Time High

₩40950.00